Mounjaro®
Starting from £179.99/mo
Start journey Learn moreFeeling cold on Mounjaro is one of the more surprising side effects people notice, particularly in the first few weeks of treatment. It tends to happen because your body is consuming less energy than it was before — and producing less heat as a result. It is not dangerous in most cases, but it is worth understanding what is behind it. Mounjaro (tirzepatide) is a prescription-only medicine; a prescriber decides whether it is suitable for you following a clinical assessment, and any new or persistent symptoms should always be discussed with the clinical team looking after you. The NHS guidance on tirzepatide lists common side effects and explains when to seek help.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Coldness is not listed as one of the most common side effects in the Mounjaro prescribing information, but it is something many people on tirzepatide report, and there is a clear physiological reason for it. When your appetite drops sharply (which Mounjaro is very effective at achieving) you take in fewer calories. Fewer calories means less metabolic fuel being burned, and burning less fuel means generating less body heat. The result is that people often feel chilly in environments where they previously felt comfortable.
This is sometimes described as a tirzepatide cold sensitivity effect, though that framing slightly overstates the directness of the link. Mounjaro does not target your temperature regulation directly. What it does is suppress hunger powerfully, and the knock-on effect on heat production is real and measurable. If you have dropped your daily intake significantly since starting treatment, a lower resting body temperature is a predictable consequence.
For most people the sensation settles as eating patterns stabilise and the body adapts. In the meantime, layering up and keeping rooms a little warmer are simple practical responses. It is not a reason to stop treatment, but it is a reason to mention it to whoever is overseeing your prescription.
There is real variation in how much this bothers people on Mounjaro, and muscle mass is a significant part of why. Muscle tissue is metabolically active; it burns calories even at rest and generates heat as it does so. Rapid weight loss, if it includes muscle alongside fat, can reduce that resting metabolic output and intensify the feeling of coldness.
This is one reason why protein intake matters during GLP-1 treatment. Eating enough protein (alongside resistance exercise where possible) helps preserve lean mass while you are losing weight. It also keeps your resting metabolism higher, which has direct implications for how cold you feel. Specific protein targets are a conversation for your prescriber or a dietitian, since individual needs vary, but the principle applies broadly.
People who were already on the slimmer side of their starting weight, or who have lost weight quickly on a higher dose, may notice the sensation more. There is also an individual difference in how people perceive temperature changes. Some find cold feet in particular are an early sign that their circulation is responding to lower energy intake. That specific pattern is worth mentioning if it is persistent.
You can read more about the full range of what Mounjaro involves before deciding whether to start treatment.
For most people, mild general coldness during active weight loss needs nothing more than a warm jumper and a conversation at their next review. But there are situations where the symptom deserves more attention.
Persistent coldness that does not ease as your intake stabilises, or that is concentrated in your hands and feet rather than general body temperature, is worth flagging promptly. Persistent cold sensations on tirzepatide can occasionally point to something else, including thyroid changes or anaemia, which can themselves develop independently during a period of significant dietary change.
Feeling cold alongside other symptoms (unusual fatigue, hair loss, or swelling) is a signal to contact your prescriber or GP sooner rather than later. These combinations sometimes reflect nutritional gaps or an underlying condition that was present before treatment but becomes more noticeable during weight loss.
The MHRA's Yellow Card scheme exists specifically for reporting unexpected effects from medicines. If you experience something that feels serious or that your clinical team does not have a clear explanation for, reporting it contributes to the ongoing safety monitoring of tirzepatide, a medicine that still carries a Black Triangle (▼) status, meaning additional post-marketing surveillance is in place.
For the majority of people it does ease. The sharpest appetite suppression tends to be most intense in the first few weeks at a new dose, which is also when the cold sensation is most pronounced. As the body adjusts to a lower but more stable intake, heat production tends to recover somewhat.
Practical steps that genuinely help: prioritise protein at every meal, add resistance training if you are able, stay well hydrated, and do not skip meals entirely even when appetite is low. Dehydration can worsen the sensation of cold, and severe restriction can slow the metabolic adaptation you need.
If you are managing a dose titration and want to understand how cost factors into planning your treatment, the Eli Lilly Mounjaro pricing information may be useful context. Separately, if you want to understand the intensity of cold sensitivity during Mounjaro treatment more fully, that question is explored in detail for people finding the effect particularly noticeable.
Our prescribers at nume review every patient's progress, not just at the start of treatment but before each repeat order. If something like persistent coldness is bothering you, aftercare is available seven days a week. Your prescription is reviewed by a real clinician each time, and your pen arrives in plain packaging via DPD, tracked to your door. That ongoing access to clinical support is the right place to raise symptoms that persist.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.